411 related articles for article (PubMed ID: 29605736)
41. Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay.
García-Caballero M; Van de Velde M; Blacher S; Lambert V; Balsat C; Erpicum C; Durré T; Kridelka F; Noel A
Sci Rep; 2017 Jan; 7():41494. PubMed ID: 28128294
[TBL] [Abstract][Full Text] [Related]
42. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].
Zou JD; Fu HY; Xu W; Lü ZH; Cao HY; Luan XY
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):461-4. PubMed ID: 21875489
[TBL] [Abstract][Full Text] [Related]
43. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations.
Franchi A; Gallo O; Massi D; Baroni G; Santucci M
Cancer; 2004 Sep; 101(5):973-8. PubMed ID: 15329906
[TBL] [Abstract][Full Text] [Related]
44. Lymphatic system: an active pathway for immune protection.
Liao S; von der Weid PY
Semin Cell Dev Biol; 2015 Feb; 38():83-9. PubMed ID: 25534659
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
[TBL] [Abstract][Full Text] [Related]
46. Lymphatic vessels regulate immune microenvironments in human and murine melanoma.
Lund AW; Wagner M; Fankhauser M; Steinskog ES; Broggi MA; Spranger S; Gajewski TF; Alitalo K; Eikesdal HP; Wiig H; Swartz MA
J Clin Invest; 2016 Sep; 126(9):3389-402. PubMed ID: 27525437
[TBL] [Abstract][Full Text] [Related]
47. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
48. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
49. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
[TBL] [Abstract][Full Text] [Related]
50. Tumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions.
Garnier L; Gkountidi AO; Hugues S
Front Immunol; 2019; 10():720. PubMed ID: 31024552
[TBL] [Abstract][Full Text] [Related]
51. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
[TBL] [Abstract][Full Text] [Related]
52. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
53. Cancer stem cells, lymphangiogenesis, and lymphatic metastasis.
Li S; Li Q
Cancer Lett; 2015 Feb; 357(2):438-47. PubMed ID: 25497008
[TBL] [Abstract][Full Text] [Related]
54. Role of lymphangiogenic factors in tumor metastasis.
He Y; Karpanen T; Alitalo K
Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
[TBL] [Abstract][Full Text] [Related]
55. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
[TBL] [Abstract][Full Text] [Related]
56. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance.
Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M
J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622
[TBL] [Abstract][Full Text] [Related]
57. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis.
Goes RS; Carvalho JP; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho FM
Int J Gynecol Pathol; 2012 Jan; 31(1):8-14. PubMed ID: 22123718
[TBL] [Abstract][Full Text] [Related]
58. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma.
Keser SH; Kandemir NO; Ece D; Gecmen GG; Gul AE; Barisik NO; Sensu S; Buyukuysal C; Barut F
Kaohsiung J Med Sci; 2017 Apr; 33(4):171-180. PubMed ID: 28359404
[TBL] [Abstract][Full Text] [Related]
59. [Importance of lymphangiogenesis and ultrastructure of lymphatic capillaries in metastasis of malignant melanoma].
Rovenská E
Vnitr Lek; 2014; 60(7-8):582-5. PubMed ID: 25130633
[TBL] [Abstract][Full Text] [Related]
60. Targeted treatment for lymphedema and lymphatic metastasis.
Tervala T; Suominen E; Saaristo A
Ann N Y Acad Sci; 2008; 1131():215-24. PubMed ID: 18519974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
